Nomogram could predict treatment-induced hearing loss in head and neck cancer

Reuters Health - 16/12/2020 - A nomogram that predicts hearing loss after head and neck cancer treatment has the potential to inform pre- and post-treatment counseling, researchers say. The nomogram uses the patient's age, chemotherapy regimen, baseline hearing level, and location of the tumor to predict hearing after treatment, principal author Dr. Jay Piccirillo of Washington University School of Medicine in St. Louis told Reuters Health by email. "An app has been created but it is not yet available, as ongoing testing and validation has been slowed by the COVID pandemic." "Ultimately, the nomogram could be provided within standard audiometry software for use in the clinic," said Dr. Piccirillo, who is Editor of JAMA Otolaryngology-Head and Neck Surgery. "This will require additional software work to integrate the app and instructional information to help clinicians correctly engage in risk discussions with the patient." As reported in that journal, Dr. Pic...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 16 December, 202022 December, 2020